General MedicationsORALGeneric
DOXYCYCLINE HYCLATE
DOXYCYCLINE HYCLATE
Standard Dose
EQ 100MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DOXYCYCLINE HYCLATE is listed in Drugs@FDA under application 063187 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE HYCLATE Form and strength CAPSULE, COATED PELLETS;ORAL - EQ 100MG BASE Sponsor PLIVA Submission history Latest submission status date: 2025-03-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOXYCYCLINE HYCLATE is listed in Drugs@FDA under application 063187 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE HYCLATE Form and strength CAPSULE, COATED PELLETS;ORAL - EQ 100MG BASE Sponsor PLIVA Submission history Latest submission status date: 2025-03-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.